Method for improving osteogenic differentiation efficiency of human amniotic mesenchymal stem cells and application thereof

A technology for stem cell and osteogenic differentiation, applied in biochemical equipment and methods, animal cells, vertebrate cells, etc., can solve the problem of undiscovered human-derived factor stem cells, etc., to improve the efficiency of osteogenic differentiation and promote expression. and activity, the effect of avoiding the difficulty of osteoblasts

Inactive Publication Date: 2017-03-15
AFFILIATED HOSPITAL OF ZUNYI MEDICAL COLLEGE
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, so far, no human-derived factors have been...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving osteogenic differentiation efficiency of human amniotic mesenchymal stem cells and application thereof
  • Method for improving osteogenic differentiation efficiency of human amniotic mesenchymal stem cells and application thereof
  • Method for improving osteogenic differentiation efficiency of human amniotic mesenchymal stem cells and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1: Method and Application of Improving Osteogenic Differentiation Efficiency of Human Amniotic Mesenchymal Stem Cells

[0023] 1. Isolation and culture of human amniotic mesenchymal stem cells

[0024] The amniotic membrane was bluntly removed from the fresh placenta of healthy full-term cesarean section, and the amniotic membrane was washed with D-Hank's solution containing 1% double antibody (final concentration: penicillin: 100 IU / mL, streptomycin: 100 IU / mL, fresh before use). Preparation) repeatedly rinse the amniotic membrane to remove residual blood stains and surface mucus. Cut the amniotic membrane into 1-3 cm 2 Divide into 50 mL centrifuge tubes, add 0.05% trypsin digestion solution containing 0.02% EDTA-2Na about 2 times the volume of amnion tissue, and digest in a constant temperature water bath at 35-37 ℃ at 150-185rpm for about 30 minutes , after filtering through a 300-mesh stainless steel filter, discard the digestion solution containing amniot...

Embodiment 2

[0031] Example 2. The use of human amniotic mesenchymal stem cells to promote osteogenesis in other aspects

[0032] Human amniotic mesenchymal stem cells are induced to differentiate into osteoblasts in vitro by the induction composition of the present invention, and can be used as seed cells for bone tissue engineering and cell transplantation. It has a certain preventive effect on fractures and bone metabolic diseases. Using the induction composition of the present invention to induce differentiation of human amniotic mesenchymal stem cells as seed cells to replace osteoblasts can avoid the problems of difficult acquisition of osteoblasts in vitro and high immunogenicity.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for improving osteogenic differentiation efficiency of human amniotic mesenchymal stem cells. The method adds an induction composition in the human amniotic mesenchymal stem cells, wherein the composition comprises 0.1-2g/L of hyaluronic acid, 0-200mg/L of prostaglandin receptor-2 selective agonist, 1-100nmol/L of dexamethasone, 0-10nmol/L of beta-glycerophosphate and 1-100mg/L of ascorbic acid. Compared with a conventional inducing method, the osteogenic differentiation efficiency of the human amniotic mesenchymal stem cells can be significantly improved, expression and activity of alkaline phosphatase are promoted, and expression of osteogenesis-related genes of RunX2, Osx, BSP, Ocn, ALP, Col1a1 and the like and formation of mineralized calcium nodules are enhanced. The method for improving the osteogenic differentiation efficiency of the human amniotic mesenchymal stem cells can be applied in osteogenic differentiation of the human mesenchymal stem cells, and applied in bone diseases of bone defects, bone trauma and the like.

Description

technical field [0001] The invention belongs to the technical field of stem cell biotechnology and bone tissue engineering, and relates to a method and application for improving the osteogenic differentiation efficiency of human amniotic mesenchymal stem cells. Background technique [0002] Bone damage or defect due to trauma, infection, degenerative disease, tumor resection and other reasons is a common and frequently-occurring disease in orthopedic diseases. Taking osteoarthritis as an example, there are currently about 150 million patients in my country. WHO estimates that by 2025, there will be more than 800 million patients worldwide. The number is second only to cardiovascular-related diseases, and it has become an important disease that seriously affects human health. At present, the repair and functional reconstruction of bone defects has become a major problem in the medical field because traditional treatment methods are difficult to achieve ideal results. In rece...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/077C12N5/0775A61L27/38
CPCA61L27/3834A61L27/3847A61L2430/02C12N5/0654C12N2500/34C12N2500/38C12N2500/42C12N2501/30C12N2501/905C12N2506/1392
Inventor 肖建辉张令涛刘如明
Owner AFFILIATED HOSPITAL OF ZUNYI MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap